Quick search
Advanced search in
Research outcomes
Field to searchTerm
Add rule
Filters (1 )
  • Access Mode (1)
    Clear
  • Research Type (4)
  • Funder (2)
  • Type (11)
  • Language (8)
  • Community (2)
  • Content Provider (62)
  • Access Mode (1)
    Clear
  • Research Type (4)
  • Funder (2)
  • Type (11)
  • Language (8)
  • Community (2)
  • Content Provider (62)
Download Results
48 research outcomes, page 1 of 5

<p>A mathematical model for the transmission of SARS is developed. In addition to dividing the population into susceptible (high and low risk), exposed, infected, quarantined, diagnosed and recovered classes, we have included a class called untraced. The model simulates...

  • publication . Doctoral thesis . 2011
    Open Access German

    SARS („severe acute respiratory syndrome”), a respiratory disease in humans, appeared in November 2002 for the first time. The causative agent of this disease is the SARS-associated coronavirus. Its replication machinery is maintained by the catalytic activity of a cyst...

  • publication . Doctoral thesis . 2008
    Open Access German

    The abstract gives a detail description on the topic of the lung plaque epidemic in the Manchuria (1910-1914). It depicts the cause, spread and measure both on the part of government and medicine against it and compares the efforts with those China had during the SARS E...

  • other research product . 2020
    Open Access English
    Publisher: Virginia Tech

    The sudden outbreak of severe acute respiratory syndrome (SARS) in Singapore in 2003 was a grave crisis for the tourism industry as a whole and highlights the importance of effectively managing and planning for such occurrences. This study looks at the particular conseq...

  • In this work protease inhibitors for SARS-CoV-PLpro were developed to find new active drugs against the SARS-Coronavirus. A new approach in combatting HIV was tried by blocking elongin-C. The computer-aided search for new SARS-CoV-PLpro inhibitors began with the analysi...

  • Potential targets in antiviral therapy against SARS are the viral cysteine proteases SARS-CoV-Mpro and SARS-CoV-PLpro which are essential enzymes for the viability and the propagation of the virus. These are outstanding targets for the development of new protease inhibi...

  • 48 research outcomes, page 1 of 5
    Last index information